Basiliximab and mycophenolate mofetil in combination with low-dose cyclosporine and methylprednisolone effectively prevent acute rejection in kidney transplant recipients

Transplantation Proceedings

Volumn 37, Issue 10, 2005, Pages 4230-4234

  Kovac, D ^a   Kotnik, V ^a   Kandus, A ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; COTRIMOXAZOLE; CYCLOSPORIN A; DILTIAZEM; GANCICLOVIR; ISONIAZID; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3;

ADULT; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RATE; KIDNEY GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; MYCOSIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VIRUS INFECTION;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; AZATHIOPRINE; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; METHYLPREDNISOLONE; MIDDLE AGED; MYCOPHENOLIC ACID; RECOMBINANT FUSION PROTEINS; REOPERATION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 29544439721     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.11.054     Document Type: Article

References (20)

1. J. Kovarik, B.D. Kahan, P.R. Rajagopalan Population pharmacokinetics and exposure-response relationships for basiliximab in kidney transplantation Transplantation 68 1999 1288
2. B.D. Kahan, P.R. Rajagopalan, M. Hall United States Simulect Renal Study Group Reduction of the occurrence of acute cellular rejection among renal alograft recipients treated with basiliximab, a chimeric anti-interleukin-2- receptor monoclonal antibody Transplantation 67 1999 276
3. B. Nashan, R. Moore, P. Amlot CHIB 201 International Study Group Randomized trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients Lancet 350 1997 1193
4. A.C. Webster, E.G. Playford, G. Higgins Interleukin 2 receptor antagonists for renal transplant recipients a meta-analysis of randomized trials Transplantation 77 2004 166
5. D. Adu, P. Cockwell, N.J. Ives Interleukin-2 receptor monoclonal antibodies in renal transplantation meta analysis of randomised trials BMJ 326 2003 789
6. European Multicentre Trial Group European multicentre trial of cyclosporine in renal transplantation 10-year follow-up Transplant Proc 25 1993 527
7. S.V. Onrust, L.R. Wiseman Basiliximab Drugs 57 1999 207
8. European Mycophenolate Mofetil Cooperative Study Group Mycophenolate mofetil in renal transplantation 3-year results from the placebo-controlled trial Transplantation 68 1999 1
9. T.H. Mathew Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation results of three years Transplantation 65 1998 1450
10. US Renal Transplant Mycophenolate Mofetil Study Group Mycophenolate mofetil in cadaveric renal transplantation Am J Kidney Dis 34 1999 296
11. H. Meier-Kriesche, A.O. Ojo, J.A. Amdorfer Mycophenolate mofetil decreases the risk for chronic renal allograft failure Transplant Proc 33 2001 1005
12. V. Kliem, A. Boeck, U. Eisenberger Treatment of chronic renal allograft failure by addition of mycophenolate mofetil single-center experience in 40 patients Transplant Proc 31 1999 1312
13. T. Tojimbara, I. Nakajima, S. Sato Results of kidney transplantation in patients receiving MMF- or MMF and basiliximab-contatining immunosuppression Transplant Proc 36 2004 2087
14. F. Vincenti Interleukin-2 receptor antagonists and aggressive steroid minimization strategies for kidney transplant patients Transpl Int 17 2004 395
15. European Mycophenolate Mofetil Cooperative Study Group Placebo-controlled study of mycophenolate mofetil combined with cyclosporine and corticosteroids for prevention of acute rejection Lancet 345 1995 1321
16. J.M. Kovarik, M.D. Pescovitz, H.W. Sollinger Differential influence of azathioprine and mycophenolate mofetil on the disposition of basiliximab in renal transplant patients Clin Transplant 15 2001 123
17. J.G. Lawen, E.A. Davies, G. Mourad Randomized double-blind study of immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with mycophenolate mofetil-containing triple therapy in renal transplantation Transplantation 75 2003 37
18. G. Opelz, B. Döhler Cyclosporine and long-term kidney graft survival Transplantation 72 2001 1267
19. K. Midtvedt, P. Fauchald, S. Bergan C2 monitoring in maintenance renal transplant recipients is it worthwhile? Transplantation 76 2003 1236
20. W.S. Cherikh, H.M. Kauffman, M.A. McBride Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation Transplantation 76 2003 1289